NASDAQ : TELA

TELA Bio, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 0.8101 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 36.57M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

TELA Bio, Inc. (TELA) reported revenue of 79.91M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue79.91M80.28M69.30M58.45M41.42M29.46M
Cost of Revenue25.34M25.55M22.43M17.96M13.57M10.35M
Gross Profit54.57M54.72M46.87M40.49M27.85M19.12M
Selling, General & Admin78.66M78.88M79.37M74.57M57.11M41.52M
Research & Development9.54M9.22M8.81M9.62M8.94M6.74M
Amortization of Goodwill & Intangibles380.00K380.00K380.00K380.00K804.00K304.00K
Operating Expenses88.58M88.48M88.56M84.57M66.86M48.57M
Operating Income-34.01M-33.76M-41.70M-44.08M-39.01M-29.45M
Interest Expense-6.97M-5.25M-5.29M-5.22M-4.05M-3.60M
Other Non Operating Income (Expenses)952.00K1.29M1.42M2.63M-10.00K-228.00K
EBT Excluding Unusual Items-40.03M-37.71M-45.56M-46.66M-43.07M-33.28M
Gain (Loss) on Sale of Assets7.58M
Other Unusual Items-888.00K-888.00K-1.23M
Pretax Income-40.91M-38.60M-37.98M-46.66M-44.30M-33.28M
Income Tax Expense265.00K230.00K-144.00K
Net Income-41.18M-38.83M-37.84M-46.66M-44.30M-33.28M
Net Income to Common-41.18M-38.83M-37.84M-46.66M-44.30M-33.28M
Shares Outstanding (Basic)52.96M46.95M28.53M22.87M16.27M14.47M
Shares Outstanding (Diluted)52.96M46.95M28.53M22.87M16.27M14.47M
EPS (Basic)-0.78-0.83-1.33-2.04-2.72-2.30
EPS (Diluted)-0.78-0.83-1.33-2.04-2.72-2.30
Free Cash Flow-31.62M-28.67M-42.58M-41.47M-41.62M-31.06M
Free Cash Flow Per Share-0.60-0.61-1.49-1.81-2.56-2.15
Gross Margin68.29%68.17%67.63%69.27%67.24%64.89%
Operating Margin-42.56%-42.05%-60.17%-75.40%-94.18%-99.96%
Profit Margin-51.53%-48.37%-54.61%-79.83%-106.95%-112.94%
Free Cash Flow Margin-39.57%-35.71%-61.45%-70.94%-100.49%-105.42%
EBITDA-33.01M-32.74M-40.68M-43.27M-37.82M-28.92M
EBITDA Margin-41.31%-40.79%-58.71%-74.02%-91.31%-98.14%
D&A For EBITDA1.00M1.01M1.01M808.00K1.19M535.00K
EBIT-34.01M-33.76M-41.70M-44.08M-39.01M-29.45M
EBIT Margin-42.56%-42.05%-60.17%-75.40%-94.18%-99.96%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents30.42M50.84M52.67M46.73M42.02M43.93M
Cash & Short-Term Investments30.42M50.84M52.67M46.73M42.02M43.93M
Receivables9.64M10.35M10.10M9.74M6.62M4.23M
Inventory11.06M11.02M12.78M13.16M11.79M7.66M
Prepaid Expenses3.37M3.37M2.52M2.10M2.02M3.23M
Total Current Assets54.49M75.58M78.07M71.73M62.45M59.05M
Property, Plant & Equipment3.43M3.73M4.08M3.94M2.91M1.19M
Other Intangible Assets1.17M1.36M1.74M2.12M2.50M2.30M
Long-Term Deferred Tax Assets140.00K
Other Long-Term Assets651.00K750.00K2.54M265.00K
Total Assets59.74M81.42M86.57M78.05M67.86M62.54M
Accounts Payable2.88M2.31M2.15M1.67M1.53M2.41M
Accrued Expenses7.26M7.12M7.36M9.36M6.56M5.01M
Current Portion of Leases530.00K524.00K545.00K565.00K340.00K
Current Income Taxes Payable862.00K725.00K476.00K
Other Current Liabilities6.68M7.29M5.07M5.38M3.97M3.15M
Total Current Liabilities18.22M17.98M15.60M16.97M12.40M10.57M
Long-Term Debt56.08M55.65M41.12M40.52M39.92M31.49M
Long-Term Leases1.30M1.48M1.69M
Other Long-Term Liabilities1.39M1.23M380.00K
Total Liabilities75.60M75.11M58.11M59.17M53.55M42.45M
Common Stock45.00K44.00K39.00K24.00K19.00K15.00K
Additional Paid-In Capital405.10M403.74M387.06M339.65M288.36M250.06M
Retained Earnings-421.10M-397.56M-358.73M-320.89M-274.23M-229.93M
Comprehensive Income & Other84.00K91.00K90.00K91.00K150.00K-52.00K
Total Common Equity-15.87M6.31M28.46M18.88M14.30M20.10M
Shareholders' Equity-15.87M6.31M28.46M18.88M14.30M20.10M
Total Liabilities & Equity59.74M81.42M86.57M78.05M67.86M62.54M
Total Debt57.92M57.65M41.67M42.77M40.26M31.49M
Net Cash (Debt)-27.49M-6.81M11.00M3.96M1.76M12.44M
Net Cash Per Share-0.52-0.150.390.170.110.86
Filing Date Shares Outstanding44.89M44.74M39.55M24.65M19.22M14.55M
Total Common Shares Outstanding44.83M44.54M39.40M24.49M19.17M14.53M
Working Capital36.27M57.61M62.47M54.76M50.04M48.48M
Book Value Per Share-0.350.140.720.770.751.38
Tangible Book Value-17.04M4.95M26.72M16.76M11.81M17.80M
Tangible Book Value Per Share-0.380.110.680.680.621.22
Machinery3.18M4.07M3.81M3.51M3.06M
Leasehold Improvements2.54M2.93M2.51M2.31M1.88M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-41.18M-38.83M-37.84M-46.66M-44.30M-33.28M
Depreciation & Amortization1.00M1.01M1.01M808.00K1.19M535.00K
Loss (Gain) From Sale of Assets18.00K-7.58M-12.00K2.00K
Stock-Based Compensation3.20M3.80M4.36M5.03M3.99M3.66M
Other Operating Activities4.89M4.31M3.32M1.96M3.71M2.10M
Change in Accounts Receivable1.51M-110.00K-762.00K-3.06M-2.42M-1.55M
Change in Inventory-2.41M-503.00K-2.97M-2.72M-6.07M-5.19M
Change in Accounts Payable1.17M141.00K482.00K11.00K-884.00K1.60M
Change in Other Net Operating Assets662.00K1.97M-1.62M3.78M4.04M1.69M
Operating Cash Flow-31.14M-28.22M-41.59M-40.86M-40.75M-30.43M
Capital Expenditures-480.00K-448.00K-989.00K-611.00K-872.00K-627.00K
Sale of Property, Plant & Equipment1.41M1.29M5.44M12.00K
Sale (Purchase) of Intangibles-1.00M
Investing Cash Flow933.00K846.00K4.45M-599.00K-1.87M-627.00K
Long-Term Debt Issued60.00M40.00M
Total Debt Issued60.00M60.00M40.00M
Long-Term Debt Repaid-42.42M-30.00M
Total Debt Repaid-42.42M-42.42M-30.00M
Net Debt Issued (Repaid)17.58M17.58M10.00M
Issuance of Common Stock11.90M11.93M43.43M46.56M34.47M585.00K
Repurchase of Common Stock-119.00K-205.00K-369.00K-289.00K-157.00K
Other Financing Activities-3.80M-3.55M-3.46M
Financing Cash Flow25.56M25.75M43.06M46.27M40.85M585.00K
Foreign Exchange Rate Adjustments33.00K-217.00K28.00K164.00K-144.00K11.00K
Net Cash Flow-4.62M-1.84M5.94M4.97M-1.91M-30.46M
Free Cash Flow-31.62M-28.67M-42.58M-41.47M-41.62M-31.06M
Free Cash Flow Margin-39.57%-35.71%-61.45%-70.94%-100.49%-105.42%
Free Cash Flow Per Share-0.60-0.61-1.49-1.81-2.56-2.15
Levered Free Cash Flow-17.71M-16.95M-26.73M-25.81M-27.42M-19.41M
Unlevered Free Cash Flow-13.36M-13.68M-23.43M-22.55M-24.89M-17.16M
Cash Interest Paid5.70M4.72M4.07M4.62M3.39M2.93M
Change in Working Capital928.00K1.50M-4.87M-1.99M-5.34M-3.46M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization36.08M52.55M118.95M162.12M220.33M185.65M
Enterprise Value63.58M66.41M144.64M145.69M207.49M163.32M
Last Close Price0.811.183.026.6211.5012.80
PS Ratio0.460.661.722.775.326.30
PB Ratio8.324.188.5915.409.24
P/TBV Ratio10.614.459.6718.6610.43
EV/Sales Ratio0.800.832.092.495.015.54
Debt / Equity Ratio-3.659.131.462.272.811.57
Net Debt / Equity Ratio-1.731.08-0.39-0.21-0.12-0.62
Net Debt / EBITDA Ratio-0.83-0.210.270.090.050.43
Net Debt / FCF Ratio-0.87-0.240.260.100.040.40
Asset Turnover1.260.960.840.800.640.40
Inventory Turnover2.262.151.731.441.401.79
Quick Ratio2.203.404.023.333.924.55
Current Ratio2.994.215.004.235.045.58
Return on Equity (ROE)-223.35%-159.87%-281.23%-257.51%-96.28%
Return on Assets (ROA)-33.40%-25.12%-31.66%-37.76%-37.39%-24.71%
Return on Capital Employed (ROCE)-81.90%-53.20%-58.70%-72.20%-70.30%-56.70%
Earnings Yield-97.28%-73.90%-31.81%-28.78%-20.10%-17.92%
FCF Yield-86.46%-54.56%-35.80%-25.58%-18.89%-16.73%
Buyback Yield / Dilution-36.23%-64.58%-24.74%-40.58%-12.40%-11.90%